NATALIE BERNHART: Open Payments
NPI 1205944022 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 51 payments from 19 companies in 2025. Trend: 2023 $2,977 · 2024 $2,662 · 2025 $1,529
Food & beverage: $1,529
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $409 |
| GENZYME CORPORATION | 4 | $169 |
| Organon LLC | 4 | $157 |
| Lilly USA, LLC | 2 | $138 |
| Janssen Biotech, Inc. | 5 | $117 |
| PFIZER INC. | 4 | $88 |
| Arcutis Biotherapeutics, Inc. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Incyte Corporation | 2 | $47 |
| Amgen Inc. | 2 | $46 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, EBGLYSS, TREMFYA, VTAMA, Zoryve, CIBINQO.
Industry payments across FL — which companies pay providers there.
